✦ LIBER ✦

Phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement (4 nodes+) — ADEBAR study

✍ Scribed by B. Rack; W. Janni; N. Harbeck; I. Zemzoun; B. Strobl; E. Klanner; J. de Waal; C. Schindlbeck; M. Kiechle; H. Sommer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P73 Phase III study evaluating the role

✍ M. Heinrigs; H. Sommer; B. Rack; W. Janni; N. Harbeck; D. Steinfeld; D. Augustin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Non-Sentinel lymph node involvement in b

✍ P Schrenk; P Konstantiniuk; S Wölfl; S Roka; S Pöstlberger; A Haid; C Tausch; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 168 KB

The SUCCESS-Trial -toxicity analysis of

✍ W. Janni; E. Genss; B. Rack; H. Sommer; M. Rezai; A. Schneider; W. Lichtenegger; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Bi-weekly docetaxel in the adjuvant trea

✍ Hajime Abe; Hiroki Ogawa; Takashi Okino; Makoto Kato; Hirotaka Sako; Haruo Sano; 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 150 KB

Participation in phase III ADEBAR: evalu

✍ F von Bismarck; W Janni; B Rack; W Thieleke; B Strobl; D Steinfeld; D Augustin; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

P70 The ADEBAR-trial — participation in

✍ J.W. Janni; H. Sommer; B. Rack; D. Steinfeld; D. Augustine; M. Heinrigs; K. Gaug 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB